Cure your screening problems with the drug-like additives in Morpheus III.
Exclusively from Molecular
Dimensions, the new Morpheus® III screen uniquely contains a range of
small, drug-like compounds to aid protein stabilisation and
Read here about how Morpheus III and it's rational screening methodology can help your screening efforts by expanding the range of chemical space you screen.
Gorrec, F. The Morpheus II protein crystallization screen. Acta Crystallographica section F Structural Biology Communications 71: 831-837 (2015).
Gorrec, F. The current approach to initial crystallization screening of proteins is under-sampled. Journal of Applied Crystallography 46: 795-7 (2013).
Gorrec, F. The MORPHEUS protein crystallization screen. Journal Applied Crystallography 42: 1035-42.
The Morpheus® III screen was developed at the MRC-LMB, Cambridge, UK and exclusively licensed to Molecular Dimensions by LifeARC.
Page 1 of 1